Physician
Nephrology
Dr. Thomas D. Batiuk, MD
|
|
Give Review
Thomas D. Batiuk is an expert in the field of Nephrology. Thomas Batiuk is also a published doctor. He has 32 publication published. The most recent publication is: Calcineurin activity in children with renal transplants receiving cyclosporine. Thomas D. Batiuk accepts Medicare.
Publications
- Glomerular Endothelial Vesicles in a Renal Allograft: An Unusual Pattern of Immunoglobulin Deposition in a Patient With Biclonal Gammopathy of Unknown Significance.
- Enteric oxalate nephropathy in the Renal allograft: an underrecognized complication of bariatric surgery.
- Severe prolonged tacrolimus overdose With minimal consequences.
- Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: simple and objective tools to define graft function.
- Studies of Renal injury IV: The GLUT1 gene protects Renal cells from cyclosporine A toxicity.
- Kidney transplantation in the morbidly obese: complicated but still better than dialysis.
- Surveillance and modification of immunosuppression minimizes BK virus nephropathy.
- Infectious Disease prophylaxis in renal transplant patients: a survey of US transplant centers.
- Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides.
- A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol.
- Broken Kidney: traumatic fracture of a renal allograft.
- Reduced intrapatient variability of cyclosporine pharmacokinetics in Renal transplant recipients switched from oral Sandimmune to Neoral.
- Calcineurin activity in children with Renal transplants receiving cyclosporine.
- Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.
- The downstream consequences of calcineurin inhibition.
- The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes.
- Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice.
- Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium.
- Cytokine nephropathy during antilymphocyte therapy.
- Incidence and type of cancer following the use of OKT3: a single center experience With 557 organ transplants.
- The molecular immunology of Acute rejection: an overview.
- A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric Renal transplantation.
- What is the dose-Response curve for the effects of cyclosporine on calcineurin and cytokine induction in vivo?
- How do cells recover from inhibition by cyclosporine?
- Cyclosporine-treated Renal transplant patients have only partial inhibition of calcineurin phosphatase activity.
- Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients.
- Strategies to improve the immunologic management of organ transplants.
- Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.
- Correlation of pancreas allograft biopsy With radionuclide and ultrasound imaging of pancreas allografts.
- Coronary artery bypass operation in dialysis patients.
- Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine.
Schools
University of Alberta Faculty of Medicine And Dentistry
Mayo Graduate School Of Medicine
Oregon Health Sciences University
Procedures Preformed
- Biopsy
- Central Line Insertion (for Chemotherapy)
- Dialysis Access Procedures
- Hemodialysis
- View All
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
University of Alberta Faculty of Medicine
Drug Facts
| NPI NUMBER | 1922077015 | |
| NPPES Provider LastName | BATIUK | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 97210 | |
| NPPES Provider State | OR | |
| Specialty Description | Nephrology | |
| Total Claim Count | 428.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 37.0 | |
| Percent Opioid Claims | 8.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922077015 |
| Last Name Of The Provider | BATIUK |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Arnold H. Israelit, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Connie M. Rhee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Labib, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William M. Bennett, MD |
|
|
Dr. Sallie E. Israelit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas J. Norman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. McCarron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Pulliam, MD |
|
|
Dr. Kate R. Gustafson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Macy A. Martinson, MD |
|
|
Dr. Mei Zhu Peng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer W. Leach, MD |